Clusterin is a highly conserved, widely distributed glycoprotein whose biological significance is still debated. Involved in many biological processes and disease states, clusterin is induced by cell injury and tissue regression, but is repressed during cell proliferation. We have previously reported that clusterin mRNA induction is associated with epithelial cell atrophy in the rat prostate and both clusterin transcript and protein accumulated in quiescent normal human skin fibroblasts. Here we show that transient clusterin overexpression, in SV40-immortalized human prostate epithelial cells (PNT2), resulted in increased accumulation of cells in the G 0 /G 1 phases of the cell cycle, accompanied by slowdown of cell cycle progression and decrease of DNA synthesis. The activities of ornithine decarboxylase (ODC) and Sadenosylmethionine decarboxylase (AdoMetDC), and the level of histone H3 mRNA (markers of cell proliferation) concomitantly decreased, while Gas1 mRNA (a marker of cell quiescence) accumulated. Thus it appears that clusterin, by opposing the effect of SV40 on the proliferation rate of PNT2 cells, acts as an antioncogene in the prostate, suggesting a role for this gene in controlling proliferation of normal and transformed prostate epithelial cells.
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Clusterin is a heterodimeric-secreted glycoprotein consisting of two subunits, a and b, joined by a unique five-disulfide bond motif in the mature extra cellular glycosylated form (Lakins et al., 1998) . It was so named because of its capability to elicit 'clustering' of several different cell types. In the rat ventral prostate undergoing tissue regression upon surgical or pharmacological androgen ablation, clusterin gene is dramatically induced (Bettuzzi et al., 1989; Astancolle et al., 2000; Buttyan et al., 1989) . In the normal gland, clusterin is exclusively expressed in cuboidal (atrophic) epithelial cells committed to apoptosis (Bettuzzi et al., 1992; Marinelli et al., 1994) . In the same organ, clusterin mRNA undergoes linear accumulation with aging Marinelli et al., 1994) . The human counterpart of the clusterin gene is present as a single copy in the human genome and localizes to chromosome 8 (8p21) (Purrello et al., 1991; Fink et al., 1993) . Both clusterin mRNA and protein were found in most animal and human tissues, where this gene is under the control of a plethora of hormones. Although several synonyms/acronyms are still in use to name this gene/protein, among which are sulfated glycoprotein 2 (SGP-2) (Griswold et al., 1988) , testosterone-repressed prostate message 2 (TRPM-2) (Buttyan et al., 1989) , ApoJ (Burkey et al., 1991) , SP-40,40 (Murphy et al., 1988) , CLI (Jenne and Tschopp, 1989 ) and others, the name 'clusterin' has been proposed in accordance with an international consensus regarding terminology (Rosenberg and Silkensen, 1995) . This highly conserved protein has been proposed as playing important roles in many biological processes (cell adhesion and cellcell interactions, organogenesis, cell differentiation and transformation, membrane lipid remodelling and transport, reproduction, complement regulation, oxidative stress, senescence, etc.) and in many disease states (atherosclerosis, neurodegenerative and renal diseases, infertility, myocardial infarction, etc.), but most of the studies so far available are still confined to the descriptive level (Rosenberg and Silkensen, 1995) . Among these investigations, the evidence for a strong association between clusterin and apoptosis (Pearse et al., 1992) , together with the report of its up-regulation in cells surviving death (French et al., 1994; Koch Brandt and Morgans, 1996) and in mammalian senescence Gonos et al., 1998; Marinelli et al., 1994) , suggest a possible role for this gene in protecting cells from death (French et al., 1994; Koch Brandt and Morgans, 1996; Miyake et al., 2000; Viard et al., 1999) . In a recent work, different forms of clusterin have been immunologically distinguished in apoptotic and death surviving cells (Lakins et al., 1998) , suggesting that under the name 'clusterin' a family of different proteins, with different biological significance, are probably still awaiting for a better definition.
We previously reported that clusterin expression levels depend on the proliferation rate in normal human cells, being up-regulated in quiescent normal skin fibroblasts (Bettuzzi et al., 1999a) and downregulated in PHA-stimulated lymphocytes (Grassilli et al., 1991) . In view of our interest in investigating the possible involvement of clusterin in normal and pathological prostate gland proliferation and differentiation, we studied the changes in proliferation activity occurring in transiently transfected PNT2 cells, derived from normal human epithelial prostate cells by SV40-immortalization (Blanchere et al., 1998; Cussenot et al., 1991) . PNT2 cells retain characteristics typical of well-differentiated cells with respect to morphological features, cytokeratins expression profile and doubling time (Cussenot et al., 1991) .
Clusterin overexpression was driven in PNT2 cells by the LacSwitch II Inducible Mammalian Expression System (Stratagene, La Jolla, CA, USA), that includes the operator vector pCMVLac1 (the Lac repressor expressing plasmid) and the expression vector pOP-SVI-MCS. For that purpose, the full-length 1513 bp cDNA fragment coding for rat clusterin (Bettuzzi et al., 1989) was inserted into pOP-SVI-MCS to originate the pOP/SGP-2, a construct that drives clusterin overexpression under the control of the strong universal Rous Sarcoma Virus (RSV) promoter. Overall transfection efficiency in PNT2 cells was assessed by detecting the relative expression of the reporter gene EGFP (Enhanced Green Fluorescent Protein) by means of Confocal Laser Spectral Microscopy (CLSM) and comparing different transfection protocols (data not shown). Dosper reagent was chosen, because under these experimental conditions, nearly all cells appeared to be positive when observed by CLSM (data not shown). Although in most of the transfected cells the level of expression was rather low, no signs of cytotoxicity were evident. This protocol allowed us to study the possible biological effects of clusterin gene overexpression while meeting two important experimental conditions: (1) moderate/low level of transient gene overexpression, closer to physiological conditions in which clusterin is generally induced; (2) an overall transfection efficiency that was close to 100% of PNT2 cells, a condition implying no need for sorting out the positively transfected cells from the negative ones. Cotransfections with pCMVLac1, together with the mammalian expression vector pOPR13CAT carrying the chloramphenicol acetyltransferase (CAT) reporter gene, were performed to set out the conditions for gene repression. A co-transfection with 1 : 4 molar ratio (pCMVLac1 : pOPR13CAT) resulted in highly efficient repression of CAT activity. Administration of IPTG quickly induced CAT activity, starting as soon as 2 h and reaching a peak between 16 and 24 h (data not shown). Thus, for clusterin overexpression experiments, PNT2 cells were analysed within a time frame which starts from the beginning of the transfection, includes the IPTG-induction and extends to 36 h, a time interval required for completion of cell replication (PNT2 cells average doubling time: 35.9+1.6 h) (Cussenot et al., 1991) .
The vector pOP/SGP-2 allowed to introduce clusterin cDNA (Bettuzzi et al., 1989) For Northern blot analyses, total RNA was extracted and 10 mg aliquots were electrophoresed, blotted and then hybridized to the specific cDNA probes as previously described . Quantitation of the autoradiograms was obtained by densitometric scanning using a LKB Ultrascan XL densitometer. Western blot analyses were performed by chemiluminescence as previously described . Cells were harvested and directly lysed at 1008C for 10 min in SDS -PAGE loading buffer. The total protein extract, equivalent to 4610 5 cells, was then loaded on each lane and resolved by electrophoresis on 10% polyacrylamide gel. Clusterin immunoreactive bands were detected using polyclonal anti-rat clusterin antibodies commecially available, obtained from rabbits immunized with a mixture of four synthetic peptides corresponding to the following regions: amino acids residues 1 -17; 32 -48; 52 -72; 133 -148 (Upstate Biotechnology, Lake Placid, NY, USA). (a) Northern hybridization analysis performed in: Co, controls (cells co-transfected with pCMVLac1 and pOP/SGP-2; no IPTG administration); 10, 20 and 36 h, clusterin overexpressing cells (cells cotransfected with pCMVLac1 and pOP/SGP-2; IPTG administrated for the time indicated). The induced 1.8-kbp transcript coding for clusterin was detected until up to 20 h of IPTG induction. Etidium bromide staining of the total RNA samples is also shown for comparison. (b) Western blot analysis of clusterin immunoreactive bands in PNT2 cell extracts obtained from controls and clusterin overexpressing cells as in (a): accumulation of clusterin immunoreactive protein forms was evident until up to 20 h after IPTG induction. (c) the pattern of immunoreactive forms of clusterin in normal (N) and 4-day castrated rat prostate (Ca) is also shown for comparison. The result was obtained with the same polyclonal anti-rat antibodies used for (b). Under these experimental conditions, the purchased antiserum exhibited cross-reactivity between human and rat clusterin (compare Figure 1b,c) , recognizing different forms of clusterin protein. The same amount of total protein was loaded on each gel lane shown in panels b and c. Cross-reactivity was also previously observed in human prostate carcinoma specimens . The data shown are representative of four independent experiments transfected cells after IPTG induction (Figure 1a , 10 -36 h and Figure 1b , 10 -36 h). For comparison, Western blot analysis using the same policlonal antirat clusterin Ab was also performed in parallel in ventral prostate from normal ( Figure 1c, N) or 4-day castrated rat (Figure 1c , Ca). Cross-reactivity between human and rat clusterin is evident, resulting in a complex pattern both with human and rat extracts due to different clusterin protein forms consisting of the high molecular weight, not-glycosylated precursor (53 kDa), mature glycosylated forms (about 63 -65 kDa) and subunits (in the range of 29 -43 kDa). PNT2 control cells showed a very low amount of the clusterin transcript (that can only be detected by prolonged autoradiography) and basal levels of the protein. Accumulation of both clusterin mRNA and protein was evident in transiently transfected PNT2 cells at 10 h and 20 h after IPTG induction, confirming that clusterin overexpression was indeed achieved under these experimental conditions. However, clusterin transcript decreased markedly 36 h after IPTG induction, returning to basal level.
During transient overexpression of clusterin in PNT2 cells following IPTG-induction, the total number of cells/plate was lower (Figure 2a ) and, consistent with that, the total amount of DNA/plate, after IPTG induction, was also lower in clusterin-overexpressing PNT2 cells with respect to controls (Figure 2b) . Thus, reduced cell growth and DNA synthesis occurred during clusterin overexpression (compare Figure 1 and Figure 2 ). This was confirmed by Flow Cytometry (FACS) analysis of PNT2 cell proliferation. The number of cells in G 0 /G 1 phases increased significantly at 10 and 20 h after IPTG administration with respect to controls, with a corresponding decrease in the number of cells in S phase and in G 2 /M phases ( Figure  2c ). This effect disappeared at 30 h, when the proliferation pattern of clusterin-overexpressing cells became similar to controls (Figure 2c ). The return to basal proliferation activity was concomitant with the drop in clusterin overexpression that we detected at 36 h after IPTG-induction (Figure 1 ), in coincidence with the average doubling time of PNT2 cells. This effect can be explained as a result of the 'dilution' of the expression plasmid, which is not duplicated, but is shared among the newly replicated cells, in concomitance with the outcome of intracellular plasmiddegradation processes.
Taken together, the above data suggest that clusterin overexpression could delay or slow down cell cycle progression. To address this, we used FACS analysis to determine the time required for PNT2 cells to proceed from G 1 to G 2 /M phases through S phase. Time-pulse BrdU incorporation into chromatin, by actively DNAsynthesizing cells, was obtained by exposing transfected, IPTG-induced cells to BrdU for 20 min, followed by repeated washing and growth in standard medium. Cells were then harvested and cell cycle progression was analysed by FACS at 2.5, 5.0 and 10.0 h after labelling ( Figure 3) . The progression through the cell cycle of control cells (Figure 3 , b -e) was faster when compared to clusterin-overexpressing cells (Figure 3, f -h) , showing that clusterin overexpression was indeed capable of slowing down cell cycle progression, extending the time interval between G 1 and G 2 /M phases. Consistent with this interpretation of the data, the level of incorporation of BrdU was clearly lower in clusterin-overexpressing cells, as shown by comparing panels c and f (grey arrows) or d and h (black arrows) of Figure 3 . This was confirmed by double fluorescence labelling and microscopy analysis of PNT2 transfected cells. In fact, Figure 4 shows that early IPTG-induced (12 h) individual PNT2 cells, exhibiting the highest levels of clusterin expression, fail to incorporate BrdU even after 12 h incubation in the presence of the analogue.
Since enhanced polyamine biosynthesis is generally associated with cell proliferation (Canellakis et al., 1989; Heby, 1981; Lowe, 1980; Luk and Casero, 1987; Pegg, 1988) , we sought to determine whether ornithine decarboxylase (ODC) and S-adenosylmethionine decarboxylase (AdoMetDC) activities, the two rate-limiting enzymes of polyamine biosynthesis, were inhibited in clusterin-overexpressing PNT2 cells during IPTG induction (Figure 5 ). At 10, 20 and 25 h after IPTG induction, both ODC (Figure 5a ) and AdoMetDC (Figure 5b ) activities were remarkably lower with respect to controls, suggesting that clusterin overexpression reduced proliferation activity. Histone H3 mRNA (Plumb et al., 1983 ) is a specific marker of the S phase of the cell cycle (Konishi et al., 1996) , while growth-arrest specific gene 1 (Gas1) is a marker (and an inducer) of cell quiescence in normal human cells (Del Sal et al., 1992 . We previously used both molecular markers to assess cell proliferation activity in different experimental systems (Bettuzzi et al., 1999a (Bettuzzi et al., ,b, 2000 . Northern blot analyses performed on clusterinoverexpressing PNT2 cells (Figure 5c ) showed a decrease in the level of histone H3 mRNA and an accumulation of Gas1 mRNA during clusterin overexpression, revealing an expression pattern consistent with decreased cell proliferation activity.
In normal human skin fibroblasts, clusterin accumulation coincided with decreased proliferation rate, being maximally expressed in cells brought to quiescence by serum starvation. (Bettuzzi et al., 1999a) . Contrariwise, in resting human lymphocytes, clusterin exhibited a dramatic down-regulation when cells were stimulated to grow by PHA treatment (Grassilli et al., 1991) . Thus, clusterin was proposed to participate in cell growth-controlling events. Evidence of clusterin association to cells regressing to an atrophic state has been reported by Marinelli et al. (1994) , and Huang et al. (1997) , who showed that surgically induced spinal cord injury resulted in acute decrease of both serum testosterone level and prostate weight, accompanied by clusterin overexpression in the gland. At 2 weeks postinjury, prostate growth resumed, but clusterin levels remained elevated and this was accompanied by decrease in the height of the ventral prostate epithelial cells, suggestive of an atrophic state of these cells.
Increases in the levels of polyamines and activities of the two regulatory enzymes of their biosynthesis, ODC and AdoMetDC, occur during cell transformation induced by growth factors, carcinogens, viruses or oncogenes (Pegg, 1988) . As a matter of fact, ODC activity was shown to be critical for cell transformation, and ODC gene was suggested to be a proto-oncogene (Auvinen et al., 1992) ; (Holtta et al., 1993) . The levels of expression of these genes were significantly higher in human prostatic carcinoma (CaP) with respect to the benign counterpart, and correlated with the degree of malignancy while, under the same conditions, clusterin was down-regulated . Clusterin and ODC gene expression are inversely correlated in other experimental models (Bettuzzi et al., 1992; Grassilli et al., 1991) and this was confirmed by the data presented here on the concomitance of clusterin overexpression and decreased polyamine biosynthesis. This suggests the hypothesis that clusterin could directly affect the regulation of polyamine metabolism, thus decreasing cell proliferation rate and possibly interfering with cell transformation processes. In human prostate specimens clusterin down-regulation is an early event during CaP progression, in that it occurs not only in highly malignant cancer but also in well-differentiated tumours . This down-regulation could result, among other mechanisms, from a specific genetic alteration or loss. Indeed, clusterin gene is a single copy gene that maps to human chromosome 8 (Purrello et al., 1991) in 8p21 (Fink et al., 1993) , a region which contains one of the most frequently Figure 3 . Transfected PNT2 cells were exposed to IPTG induction for 12 h in the presence of 20 mM BrdU, then fixed in 4% paraformaldehyde, permeabilized in 0.3% Triton X-100 in PBS for 15 min at room temperature, and subjected to double fluorescence immunocytochemistry using polyclonal anti-rat clusterin (as in Figure 1 (Bettuzzi et al., 1995) . After IPTG induction, cells were harvested 10, 20, 25 and 40 h for ODC assay, 10 and 25 h for AdoMetDC assay. Black bars, controls; white bars, clusterin-overexpressing cells. The results are expressed as % of enzymatic activity of 0 h control (no IPTG administration, 0 h=100%)+s.d. from four independent experiments. (c) PNT2 cells, as in the case of a and b, were harvested 20 and 30 h after IPTG induction. Total RNA (10 mg/lane) was hybridized to specific histone H3 and Gas1 cDNA probes. 1, 2, 4: controls; 3 and 5: clusterin-overexpressing PNT2 cells. Etidium bromide staining of total RNA is also shown for comparison. A representative result out of three independent experiments is shown deleted loci observed in prostate cancer cells, and where it has been hypothesized that one (or more) tumour suppressor genes are located (Latil et al., 1994 (Latil et al., , 1996 Emmert Buck et al., 1995) . Together with the present findings, this poses the question of whether clusterin could act as a tumour suppressor gene in prostate carcinoma. This takes on a particular meaning when considering our previous data showing a specific, dramatic and progressive accumulation of clusterin mRNA in the prostate of the ageing rat . This is due to the progressive extension, during ageing, of the cuboidal (atrophic) clusterinexpressing epithelium at the expense of the columnar one (not expressing clusterin) , an event that is not accompanied by increase in apoptotic activity. In fact, both DNA content and weight of the gland do not decrease upon ageing . During rat prostate ageing the epithelial cells tend to become atrophic, quiescent and long-lived; which may explain why, contrary to humans, agerelated malignant transformation of the prostate is very unlikely to occur in this species. The data presented here suggest that clusterin overexpression could induce the quiescent state of the prostatic epithelial cells, exerting a role in preventing pathological proliferation of the secretory epithelia.
The biological effects obtained in human prostate epithelial cells immortalized by stable overexpression of SV40 large-T antigen (Cussenot et al., 1991) take on a particular meaning when considering that the expression of the SV40 early genes (T and t antigen, Tag), driven by the prostate specific promoter probasin in the autochthonous transgenic adenocarcinoma of the mouse prostate (TRAMP) model, spontaneously develops metastatic CaP, closely mimicking progressive forms of human disease (Greenberg et al., 1995) . Our data suggest that clusterin gene could be considered a possible candidate for an important role in the control of normal and pathological cell proliferation, acting as an anti-oncogene in the prostate. This role would result from different functions played, through previously unknown mechanism(s), by the different alternative intracellular forms of the protein that have been reported within separate intracellular compartments (Lakins et al., 1998) .
